- Home
- NERV vs TRIB Comparison
NERV vs TRIB Comparison
Compare NERV & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NERV
- TRIB
- Stock Information
- Founded
- NERV 2007
- TRIB 1992
- Country
- NERV United States
- TRIB Ireland
- Employees
- NERV N/A
- TRIB N/A
- Industry
- NERV Biotechnology: Pharmaceutical Preparations
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- NERV Health Care
- TRIB Health Care
- Exchange
- NERV Nasdaq
- TRIB Nasdaq
- Market Cap
- NERV 12.6M
- TRIB 13.0M
- IPO Year
- NERV 2014
- TRIB N/A
- Fundamental
- Price
- NERV $1.73
- TRIB $0.68
- Analyst Decision
- NERV Hold
- TRIB
- Analyst Count
- NERV 1
- TRIB 0
- Target Price
- NERV $5.00
- TRIB N/A
- AVG Volume (30 Days)
- NERV 12.1K
- TRIB 2.4M
- Earning Date
- NERV 08-05-2025
- TRIB 08-13-2025
- Dividend Yield
- NERV N/A
- TRIB N/A
- EPS Growth
- NERV N/A
- TRIB N/A
- EPS
- NERV 0.83
- TRIB N/A
- Revenue
- NERV N/A
- TRIB $61,555,000.00
- Revenue This Year
- NERV N/A
- TRIB $13.51
- Revenue Next Year
- NERV N/A
- TRIB $13.14
- P/E Ratio
- NERV $2.06
- TRIB N/A
- Revenue Growth
- NERV N/A
- TRIB 8.31
- 52 Week Low
- NERV $1.15
- TRIB $0.48
- 52 Week High
- NERV $3.50
- TRIB $3.44
- Technical
- Relative Strength Index (RSI)
- NERV 50.22
- TRIB 51.77
- Support Level
- NERV $1.57
- TRIB $0.63
- Resistance Level
- NERV $1.88
- TRIB $0.77
- Average True Range (ATR)
- NERV 0.09
- TRIB 0.08
- MACD
- NERV -0.02
- TRIB 0.01
- Stochastic Oscillator
- NERV 52.03
- TRIB 42.76
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.